Protodesnitazene
From Wikipedia, the free encyclopedia
Pharmaceutical compound
| Identifiers | |
|---|---|
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| Chemical and physical data | |
| Formula | C23H31N3O |
| Molar mass | 365.521 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Protodesnitazene is a benzimidazole derivative which has been sold as a designer drug, and has potent opioid effects. It has been identified in Canada, Australia, the United Kingdom and Finland, first appearing in early 2025.[1][2][3][4][5][6][7][8]
References
- ↑ "High Risk Substance Detected In Fentanyl Trafficking Investigation". Sarnia Police Service. 13 March 2025. Retrieved 17 August 2025.
- ↑ "Fredericton Police Warn of New, Potentially Fatal Street Drug". City of Fredericton. Fredericton Police. 9 April 2025. Retrieved 17 August 2025.
- ↑ "New nitazene (strong opioid) Protodesnitazene detected" (PDF). Queensland Health. Queensland Government. March 2025. Retrieved 17 August 2025.
- ↑ Gwynn L (4 April 2025). "Nitazines found in black market vapes as criminals make new variations to evade detection". ABC News. Australian Broadcasting Corporation. Retrieved 17 August 2025.
- ↑ "Rapid Action Drug Alerts and Response (RADAR) Alert: Nitazenes". Public Health Scotland. NHS Scotland. 12 August 2025. Retrieved 17 August 2025.
- ↑ "Customs warns about an extremely dangerous substance in the drug trade". Finnish Customs. 20 October 2025. Retrieved 22 August 2025.
- ↑ Clayton J, Shi L, Robertson MJ, Skiniotis G, Michaelides M, Stavitskaya L, Shen J. A putative binding model of nitazene derivatives at the μ-opioid receptor. Neuropharmacology. 2025 Aug 1;273:110437. doi:10.1016/j.neuropharm.2025.110437 PMID 40185362
- ↑ Hardwick EK, Couch AN, Davidson JT. Comparison of Activation Techniques for the Identification of Nitazene Analogs Using the NIST/NIJ Data Interpretation Tool. Rapid Commun Mass Spectrom. 2026 Mar 15;40(5):e70004. doi:10.1002/rcm.70004 PMID 41359886